Therapy Insight: The Recognition and Treatment of Retinal Manifestations of Systemic Vasculitis Petros Aristodemou; Miles Stanford Disclosures Nat Clin Pract Rheumatol. 2006;2 (8):443-451. 0 ...

We are thrilled to report excellent progress in the ARTEMIS Phase 3 trial, with enrollment driven by robust interest from retina specialists and ...

ARTEMIS Phase 3 trial enrollment exceeding expectations; driven by strong retina specialist and patient enthusiasm for a potential One And Done™ therapy for wet AMD - ARTEMIS enrollment completion ...

More information: Melaku N. Getahun et al, FS-Net: Full scale network and adaptive threshold for improving extraction of micro-retinal vessel structures, Pattern Recognition Letters (2025).

InFocus is the only global CRO purpose-built for retina. Founded by retina stakeholders, the company leverages deep therapeutic expertise, long-standing relationships with top-per ...

Completed Phase 3 enrollment for DURAVYU™ in wet AMD with over 800 patients enrolled and randomized – – LUGANO and LUCIA ...

UB faculty member Steven J. Fliesler has been named the 2022 recipient of the Retina Research Foundation’s (RRF) Paul Kayser International Award in Retina Research presented by the International ...

News Release 11-Sep-2023 Seeing success and recognition for research on retinal disease and regeneration SUNY Optometry Ph.D. students take top honors with national awards Grant and Award Announcement ...